FDA may OK COVID boosters for 16- and 17-year-olds as soon as next week

The Food and Drug Administration could authorize COVID-19 boosters from Pfizer Inc. and BioNTech SE for use in 16- and 17-year-olds as soon as next week as concerns rise over a new, possibly more transmissible variant, according to a person familiar with the planning.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.